Real-time context
Company earnings results and notable reporting developments.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreRein Therapeutics Inc. (NASDAQ:RNTX) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read more60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreXcel Brands, Inc. (NASDAQ:XELB) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreODTX (NASDAQ:ODTX) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreInhibikase Therapeutics, Inc. (NASDAQ:IKT) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreBIR (NASDAQ:BIR) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreJAG (NASDAQ:JAG) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreMinerva Neurosciences, Inc. (NASDAQ:NERV) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreOS Therapies Incorporated (NYSE:OSTX) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read morePlus Therapeutics, Inc. (NASDAQ:PSTV) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreDermata Therapeutics, Inc. (NASDAQ:DRMA) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreMBX Biosciences, Inc. Common Stock (NASDAQ:MBX) is scheduled to report its Q3 earnings results on August 21, 2026 after market close.
Read morePhio Pharmaceuticals Corp. (NASDAQ:PHIO) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreTraws Pharma, Inc. (NASDAQ:TRAW) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreUnicycive Therapeutics, Inc. (NASDAQ:UNCY) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreHealthcare Triangle, Inc. (NASDAQ:HCTI) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreEni S.p.A. (NYSE:E) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreIFA (NASDAQ:IFA) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreRenaissance IPO ETF (AMEX:IPO) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read more
